Taking Mounjaro and Bisoprolol Together: The Facts

The biggest myth: 'beta-blockers and Mounjaro simply can't be taken together'

This one comes up regularly. The reality is more nuanced than an outright ban. Bisoprolol is a selective beta-1 adrenergic blocker prescribed for angina, heart failure, hypertension and arrhythmias. Tirzepatide is a dual GIP and GLP-1 receptor agonist used for weight management. The NHS tirzepatide medicines page does not list bisoprolol as a contraindicated combination, and the prescribing information for both medicines stops well short of saying the two are incompatible.

What the evidence does show is that each medicine influences heart rate independently. Bisoprolol slows the heart as part of its intended effect. Tirzepatide can cause a modest increase in resting heart rate in some people, particularly during dose escalation. These effects don't cancel each other out neatly, and in someone with an existing cardiac condition they merit closer monitoring. That is a reason for careful clinical assessment, not automatic exclusion.

People who manage a heart condition alongside obesity face a genuine dilemma: leaving significant excess weight unaddressed carries its own cardiovascular risk. A prescriber weighing that balance needs your full drug history in front of them, not a rule of thumb you found online. If you're curious how our clinical team approaches complex medication histories, the about us page sets out how every consultation is reviewed.

What 'slowed gastric emptying' actually means for your bisoprolol dose

Tirzepatide reduces the speed at which the stomach empties its contents into the small intestine. For most medicines this effect is modest and clinically manageable, but it is worth understanding what it means in practice.

Bisoprolol is taken orally once daily, usually in the morning. If gastric emptying slows significantly after a Mounjaro dose, the rate at which bisoprolol reaches peak plasma concentration may shift. In the real world this rarely translates into a meaningful clinical problem for most people, but it is a reason to be consistent: take bisoprolol at the same time each day, and if you notice your resting heart rate behaving differently after starting Mounjaro or after a dose increase, flag it with your prescriber promptly. Don't adjust your bisoprolol dose on your own.

The same absorption consideration applies to other oral medicines people commonly take alongside tirzepatide. Our guide on lansoprazole and Mounjaro covers the gastric-emptying question in detail if your medication list includes a proton pump inhibitor too. Mounjaro's effect on oral absorption is one of several reasons the full drug review before prescribing matters, it is not simply a box-tick.

The masked-symptom question: hypoglycaemia and beta-blockers

This is the more practically important consideration, and it applies most directly to people who take both bisoprolol and a medicine that can cause hypoglycaemia (such as insulin or a sulfonylurea) alongside Mounjaro.

Tirzepatide on its own carries a low risk of hypoglycaemia in people without diabetes. When used for weight management in adults without diabetes, that risk is not a primary concern. The picture changes if you also take an insulin secretagogue or insulin: bisoprolol blocks the adrenaline-driven symptoms of low blood sugar (rapid heartbeat, tremor, anxiety), leaving sweating and confusion as the main remaining warnings. The January 2026 MHRA Drug Safety Update on GLP-1 medicines is worth reading if you manage a complex medication regimen; it outlines the monitoring considerations for this drug class in detail.

If your only glucose-lowering medicine is Mounjaro and you don't have type 2 diabetes managed with insulin or sulfonylureas, the masked-hypoglycaemia concern is largely theoretical rather than an active day-to-day risk. A prescriber can clarify which category applies to you.

Telling your prescriber (and your GP) before you start

Before Mounjaro is prescribed through any regulated service, a full medicines review should happen. At nume, a GPhC-registered Independent Prescriber (a real clinician, not software) reads your consultation answers the same day and considers every medicine you have listed, including bisoprolol. GP notification follows in line with GPhC guidance, which matters here: your GP surgery holds your bisoprolol prescription and is best placed to monitor blood pressure and heart rate as your weight changes.

Weight loss itself changes cardiovascular parameters. As body weight falls, blood pressure often improves, which in some people means their bisoprolol dose becomes higher than necessary over time. That is a welcome clinical problem, but it needs GP oversight. If you have also wondered whether tirzepatide affects sexual health, our page on Mounjaro and ED covers how the treatment can interact with that aspect of cardiovascular wellbeing. Just make sure your GP knows you've added Mounjaro to the mix so they can review whether your current dose still fits.

If cost is a factor in your thinking, the Mounjaro price comparison guide explains what a legitimate private prescription typically includes and what to look for. And if you take another medicine that interacts with cardiovascular pathways, the Mounjaro and propranolol page covers a closely related beta-blocker. For a full overview of the treatment itself, the Mounjaro treatment page is the place to start.

Speak to our prescribers if you take bisoprolol and want to understand whether Mounjaro is appropriate for you, the consultation is free, and the clinical review covers your full medication picture. If nausea is part of your experience and you're wondering about remedies, our guide on using Pepto-Bismol alongside Mounjaro is worth a read before reaching for the medicine cabinet.